UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.   20549
FORM 10-Q

	[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
		SECURITIES EXCHANGE ACT OF 1934

		For the Quarterly Period Ended March 31, 1999

or

	[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF    
		THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 1-10281

Smith Corona Corporation
(Exact name of registrant as specified in its charter)

              Delaware                           51-0286862      
(State or other jurisdiction of                (I.R.S. Employer
 incorporation or organization)                 Identification No.)

842 Bennie Road, Cortland, New York 13045
(Address of principal executive offices)	(Zip Code)

(607) 753-6011
(Registrant's telephone number, including area code)


	Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes   X  		No      

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

	Indicate by check mark whether the registrant has filed all documents 
and reports required to be filed by Sections 12, 13, or 15(d) of the 
Securities Exchange Act of 1934 subsequent to the distribution of 
securities under a plan confirmed by a court.
Yes   X  		No      

	Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.

                                                    Outstanding at
          Class                                       May 5, 1999
Common Stock, par value $.001                          3,138,679
per share

SMITH CORONA CORPORATION AND SUBSIDIARIES

INDEX


                                                              Page

PART I.   FINANCIAL INFORMATION

Item 1.   Consolidated Financial Statements

          Condensed Consolidated Balance Sheets - 
          March 31, 1999 and June 30, 1998                       1

          Consolidated Statements of Operations - For the
          three and nine months ended March 31, 1999
          and 1998                                               2

          Consolidated Statement of Changes in Stockholders'
          Equity - For the nine months ended 
          March 31, 1999                                         3

          Consolidated Statements of Cash Flows - For the
          nine months ended March  31, 1999 and 1998             4

          Notes to Consolidated Financial Statements           5-8


Item 2.   Management's Discussion and Analysis of Results of
          Operations and Financial Condition                  9-12


PART II.  OTHER INFORMATION

Item 1.   Legal Proceedings                                     12

Item 6.   Exhibits and Reports on Form 8-K                      12


Signatures                                                      13

Exhibit Index                                                   14



                 SMITH CORONA CORPORATION AND SUBSIDIARIES
                  CONDENSED CONSOLIDATED BALANCE SHEETS
                          ($ in thousands)

 
                                              March 31,      June 30,
                                               1999            1998  
ASSETS                                       (unaudited)   (audited)
  Current assets:
    Cash and cash equivalents                $ 5,932        $15,293
    Accounts receivable (net of allowance
      for doubtful accounts of $509 and
      $638, respectively)                      6,278          9,492
    Inventories                                9,653         15,399
    Prepaid expenses and other current
      assets                                     752          3,090
    Total current assets                      22,615         43,274

  Property, plant and equipment, net           2,771          6,511
  Other assets                                 2,524            302

    TOTAL                                    $27,910        $50,087

LIABILITIES AND STOCKHOLDERS' EQUITY
  Current liabilities:
    Trade payables                           $ 3,761        $ 6,025
    Accrued liabilities                        8,271          8,204
    Taxes payable                              3,167          3,138
    Total current liabilities                 15,199         17,367

  Pension liability                            4,768          4,827
  Postretirement benefits                      2,343          3,846
  Other long-term liabilities                  1,641          4,007
    Total liabilities                         23,951         30,047
  Stockholders' equity:
    Common stock-3,311,228 shares
       and 3,141,654 shares issued 
       and outstanding, respectively               3              3
    Additional paid-in capital                55,779         55,512
    Deferred compensation                       (167)          (326)
    Accumulated deficit                      (51,656)       (35,149)
    Total stockholders' equity                 3,959         20,040
 
    TOTAL                                    $27,910        $50,087

See accompanying notes to consolidated financial statements. 


                    SMITH CORONA CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    ($ in thousands, except per share amounts)



                              Three months ended       Nine months ended
                                 March 31,                 March 31,
                               1999       1998          1999       1998
                                 (unaudited)              (unaudited)

Net sales                     $11,893   $15,096        $ 35,775  $46,893
Cost of goods sold             12,219    10,600          35,816   34,360
  Gross margin                   (326)    4,496             (41)  12,533
Selling, general and
  administrative expenses       4,574     7,722          15,366   19,758
Restructuring expense               -         -           1,324        -
Reorganization income               -         -               -     (249)
Gain on sale of 
  manufacturing operations          -         -               -   (3,700)
Other income                        -       (49)              -     (149)
Operating loss                 (4,900)   (3,177)        (16,731)  (3,127)
Interest (income) expense        (342)     (340)           (345)    (779)


Loss before income
  taxes and extraordinary 
  gain                         (4,558)   (2,837)        (16,386)  (2,348)
Income taxes                       26        70             121      293
Loss before
  extraordinary gain           (4,584)   (2,907)        (16,507)  (2,641)
Extraordinary gain-net              -         -               -      460
Net loss                      $(4,584)  $(2,907)       $(16,507) $(2,181)


Earnings (loss) per common 
  share-basic:
Loss before 
  extraordinary gain          $ (1.51)  $ (1.04)       $  (5.51) $  (.97)
Extraordinary gain-net              -         -               -      .16
Net loss                      $ (1.51)  $ (1.04)       $  (5.51) $  (.81)

Earnings (loss) per common
  share-diluted:
Loss before 
  extraordinary gain          $ (1.51)  $ (1.04)       $  (5.51) $  (.97)
Extraordinary gain-net              -         -               -      .16
Net loss                      $ (1.51)  $ (1.04)       $  (5.51) $  (.81)


See accompanying notes to consolidated financial statements

            				SMITH CORONA CORPORATION AND SUBSIDIARIES
         CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

                 For the nine months ended March 31, 1999
                             ($ in thousands)
                                (unaudited)

                                  Additional
                          Common  Paid-In    Deferred     Accumulated
                           Stock  Capital    Compensation Deficit     Total

Balance June 30, 1998      $  3   $55,512      $(326)    $(35,149)  $ 20,040

Net loss                      -         -          -      (16,507)   (16,507)

Exercise of Warrants          -         3          -            -          3

Deferred compensation         -       264       (264)           -          -

Amortization of deferred
  compensation                -         -        423            -        423
Balance March 31, 1999     $  3   $55,779      $(167)    $(51,656)   $ 3,959

See accompanying notes to consolidated financial statements.

                       SMITH CORONA CORPORATION AND SUBSIDIARIES
                         CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 ($ in thousands)
                                                   Nine months ended
                                                       March  31,  
                                                    1999      1998  
                                                     (unaudited)

  CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                        $(16,507)  $(2,181)
  Adjustments to reconcile net 
    loss to net cash used in
    operating activities:
      Depreciation and amortization                  2,033     1,768
      Gain on sale of manufacturing operations           -    (3,700)
      (Gain) loss on disposition of
        property, plant and equipment                 (103)       10
      Inventory provisions                           2,178       774
      Extraordinary gain                                 -      (460)
      Other noncash items                                -        16
      Changes in assets and liabilities:
          Accounts receivable                        3,214       (32)
          Inventories                                3,568    (1,927)
          Prepaid expenses and
            other current assets                     2,368    (1,578)
          Other assets                                 142       (19)
          Trade payables                            (2,264)    1,077
          Accrued liabilities and income taxes
           payable                                     274    (2,672)
          Postretirement benefits and pension
           liability                                (1,561)   (1,570)
          Other long-term liabilities               (2,366)        -
  Net cash used in
    operating activities                            (9,024)  (10,494)
  CASH FLOWS FROM INVESTING ACTIVITIES:
  Proceeds from the sale of property,
    plant and equipment                                103       100
  Proceeds from the sale of 
    manufacturing operations                             -    14,719
  Capital expenditures                                (440)   (1,804)
  Net cash provided by (used in)
    investing activities                              (337)   13,015
  Increase (decrease) in 
    cash and cash equivalents                       (9,361)    2,521
  Cash and cash equivalents:
    Beginning of period                             15,293    21,985
    End of period                                 $  5,932   $24,506

See accompanying notes to consolidated financial statements.

                 SMITH CORONA CORPORATION AND SUBSIDIARIES
              NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
                ($ and shares in thousands, except per share amounts)


NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES

The accompanying interim consolidated financial statements, although not 
necessarily indicative of results of operations for the entire fiscal year, 
include all adjustments of a normal recurring nature which are, in the 
opinion of management, necessary for a fair presentation of the results for 
the periods covered.  They have been prepared by Smith Corona Corporation 
(the "Company") without audit in accordance with the instructions to Form 
10-Q and should be read in conjunction with the consolidated financial 
statements and the notes thereto for the fiscal year ended June 30, 1998 as 
contained in the Company's Annual Report on Form 10-K.

The preparation of financial statements in conformity with generally 
accepted accounting principles requires management to make estimates and 
assumptions that affect the reported amounts of assets and liabilities and 
the disclosure of contingent assets and liabilities at the date of the 
financial statements and the reported amounts of revenue and expenses 
during the reporting periods.  Actual results could differ from those 
estimates.

NOTE 2 - CONTINGENCIES

Certain aspects of the Company's past handling and/or disposal of hazardous 
substances have been the subject of investigation by federal and state 
regulatory authorities, or have been the subject of lawsuits filed by such 
authorities or by private parties.  At March  31, 1999 and June 30, 1998, 
the Company had recorded liabilities of approximately $1,804 and $1,889, 
respectively, related primarily to remediation and monitoring of 
environmental sites.  Because of the uncertainties associated with 
assessing environmental matters, the related ultimate liabilities are not 
accurately determinable.  However, based on facts presently known, 
management does not believe that these investigations, if resolved 
adversely to the Company, would individually or in the aggregate have a 
material adverse effect on the Company's financial position or results of 
operations.

The Company was the owner and operator of manufacturing facilities in 
Groton, New York (the "Groton Site") and Cortlandville, New York (the 
"Cortlandville Site") and together,  (the "Owner/Operator Sites").  The 
Company's liability at the Owner/Operator Sites stems from groundwater 
contamination at the Cortlandville Site and soil contamination at the 
Groton Site.  The remediation program at the Cortlandville Site consists of 
round-the-clock pumping and filtering.  The soil venting with a soil 
infiltration injection system for the Groton Site remediation is now 
reduced to periodic soil and water sampling.  A decommissioning plan for 
the Groton Site has been approved and decommissioning activities have 
commenced. To the Company's knowledge, the only future costs that will be 
associated with remediation of those sites are for operation, maintenance, 
monitoring, shutdown, and post-shutdown of the systems.  The Company 
believes that it has set aside adequate reserves for the payment of 
expenses for the ongoing remediation programs at the Groton and 
Cortlandville Sites.  See Note 7 - Sale of Property, Plant and Equipment.

The Company is also a defendant or plaintiff in various other legal actions 
that have arisen in the ordinary course of its business.  It is the opinion 
of management that the ultimate resolution of these matters and the 
environmental matters discussed above will not have a material adverse 
effect on the Company's financial position or results of operations.

The ultimate determination of taxes payable is pending the outcome of 
certain legal entity reconfigurations within the Company's worldwide 
structure.  The reconfigurations are expected to be finalized prior to June 
30, 1999.  Based on the status of the related actions, management believes 
that the amount recorded as taxes payable will exceed the amounts 
ultimately due.  The Company will await final resolution of this matter 
before making any adjustment required to taxes payable.

The Company's current procurement contract for typewriters and related 
supplies and accessories provides for retroactive price increases in 
certain circumstances including shortfalls in actual purchases versus those 
forecasted.  Due to shortfalls from forecasted purchases the Company has 
incurred approximately $2,444 in retroactive price increases for the nine 
months ending March 31, 1999 which includes an estimated additional $800 
relating to expected shortfalls in the fourth quarter.  The Company 
continues discussions with its supplier to eliminate, along with other 
contractual items, the retroactive price increase provisions of the 
contract particularly for the remainder of this fiscal year.  The ultimate 
retroactive price increase for the three months ending June 30, 1999 
depends on the actual level of purchases, the outcome of discussions with 
its supplier and the outcome of certain other contract provisions.

NOTE 3 - INVENTORIES

A summary of inventories, by major classification and net of reserves, is 
as follows:

                                       March 31,       June 30,
                                        1999             1998  

Raw materials and work-in-process     $   304          $    91
Finished goods                          9,349           15,308
	Total                                $ 9,653          $15,399

NOTE 4 - EARNINGS (LOSS) PER SHARE

The following tables reconcile the numerators and denominators of the basic 
and diluted (loss) per share for the loss before extraordinary gain 
presented in the Consolidated Statements of Operations:

                                         Three months ended March 31, 1999
                                        Loss         Shares      Per-Share
                                     (Numerator)  (Denominator)    Amount

Basic Loss per Share
  Loss before extraordinary gain        $(4,584)       3,028       $(1.51)

Effect of dilutive securities
  Warrants                                   (a)          (a)
  Stock Options                              (b)          (b)
  Restricted Stock                            -           (c)

Diluted Loss per Share
  Loss before extraordinary gain        $(4,584)       3,028       $(1.51)
Note 4 - LOSS PER SHARE (cont.)
                                          Three months ended March 31, 1998
                                         Loss         Shares      Per-Share
                                      (Numerator)  (Denominator)    Amount

Basic Income per Share
  Loss before extraordinary gain        $(2,907)       2,801       $(1.04)

Effect of dilutive securities
  Warrants                                   (a)          (a)
  Stock Options                              (b)          (b)
  Restricted Stock                            -           (c)

Diluted Loss per Share
  Loss before extraordinary gain        $(2,907)       2,801       $(1.04)

                                         Nine months ended March  31, 1999
                                        Loss         Shares      Per-Share
                                     (Numerator)  (Denominator)    Amount

Basic Loss per Share
  Loss before extraordinary gain        $(16,507)      2,998       $(5.51)

Effect of dilutive securities
  Warrants                                    (a)         (a)
  Stock Options                               (b)         (b)
  Restricted Stock                             -          (c)

Diluted Loss per Share
  Loss before extraordinary gain        $(16,507)      2,998       $(5.51)

                                          Nine months ended March 31, 1998
                                        Loss         Shares      Per-Share
                                     (Numerator)  (Denominator)    Amount

Basic Loss per Share
  Loss before extraordinary gain         $(2,641)      2,718        $(.97)

Effect of dilutive securities
  Warrants                                    (a)         (a)
  Stock Options                               (b)         (b)
  Restricted Stock                             -          (c)
 
Diluted Loss per Share
  Loss before extraordinary gain         $(2,641)      2,718        $(.97)

(a) Warrants to purchase 1,512 shares of common stock at $8.50 per share 
were outstanding but were not included in the computation of diluted 
earnings per share because the exercise price was greater than the 
market price of the common shares and, accordingly they would have an 
anti-dilutive effect.  All warrants expired on March 1, 1999.

(b) Options to purchase 131 shares at March 31, 1999 and 156 at March 31, 
1998 of common stock at $6.13 per share were outstanding but were not 
included in the computation of diluted earnings per share because the 
option price was greater than the average market price of the common 
shares and, accordingly they would have an anti-dilutive effect.

(c) Restricted Stock of 173 shares at March 31, 1999 and 156 shares at 
March 31, 1998 would have an anti-dilutive effect in the computation.

NOTE 5 - RESTRUCTURING

In the first quarter ended September 30, 1998, the Company reevaluated 
its strategy and focus and deployment of its resources to take advantage 
of new and existing opportunities.  As a result, management determined, 
among other things, that the Company needed to continue transitioning its 
administrative cost structure from that of a manufacturing company to one 
of a sales and marketing company.

In connection with this strategic initiative, the Company announced a 
restructuring plan on September 28, 1998 and recorded a related pre-tax 
and post-tax charge of $1,324 in the nine months ended March 31, 1999.  
The substantial portion of this charge relates to the severance cost 
associated with the termination of approximately 130 positions, primarily 
at the Company's Cortland, New York corporate headquarters.  The affected 
employees were identified and notified as of September 28, 1998.  To a 
much lesser extent the restructuring charge also includes provisions 
related to a planned sale of the furnishings and equipment located at the 
corporate headquarters.  

In connection with the restructuring, the Company planned to sell its 
facility at 839 State Route 13 South in Cortland, New York  (See Note 7 - 
Sale of Property, Plant and Equipment).  The Smith Corona headquarters 
remains in Cortland, New York but was moved in March 1999 to a more 
efficient facility located at 842 Bennie Road, Cortland, New York.  The 
related net book value of the facility held for sale has been reclassified 
to other assets on the March 31, 1999 balance sheet. 

Management believes that the workforce reductions, relocation to more 
efficient facilities and the continued efforts to reduce certain targeted 
costs such as advertising and new product development will reduce expenses 
by approximately $9,000 annually.

NOTE 6 - LOAN AND SECURITY AGREEMENT

On February 10, 1999, the Company and its lender executed a waiver and 
amendment to its loan and security agreement (the "Loan and Security 
Agreement").  Pursuant to the provisions of the waiver and amendment, the 
Company must maintain an adjusted net worth, as defined, of not less than one 
dollar through June 29, 1999 and $2,000 thereafter.  Management believes that 
it will have adequate financing flexibility under the Loan and Security 
Agreement, as amended.

NOTE 7 - SALE OF PROPERTY, PLANT AND EQUIPMENT

On April 2, 1999, the Company completed the sale of its 422,000 square-foot 
former manufacturing facility and tool room equipment and operations.  
Additionally, the buyer agreed to complete operation, maintenance, monitoring, 
shutdown and post-shutdown activities of the remediation systems at the 
Cortlandville Site.  Although the buyer agreed to complete such remediation 
activities, the Company remains the primary obligor with the environmental 
authorities and as such will continue to carry the associated estimated 
liability for remediation activities on its balance sheet.  The net cash 
proceeds from the sale were approximately $2,089 and the Company expects to 
record a fourth quarter pre-tax and post-tax gain of approximately $365 from 
the transaction.

ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF  
                  OPERATIONS AND FINANCIAL CONDITION

The forward-looking comments in this Management's Discussion and Analysis 
of Results of Operations and Financial Condition are estimates by the 
Company's management of future performance and are subject to a variety of 
risks and uncertainties that could cause actual results to differ from 
management's current expectations.

Results of Operations

A number of significant events occurred during the nine months ended March 
31, 1999, as Smith Corona continued its transition from a manufacturing 
company to a sales and marketing organization. In October 1998, Martin D. 
Wilson began serving as senior vice president and chief financial officer 
of the Company.  In November, the Company appointed John A. Bermingham, an 
executive experienced in consumer electronics and office product 
management, to the position of president and chief executive officer.  In 
December 1998, Vincent T. Abbatiello was named vice president of sales.

During the second and third quarter, the management team continued 
implementing the restructuring plan announced in late September.  Staff 
streamlining in conjunction with the 60-day notice period began in late 
November and continued through the third quarter, resulting in the 
elimination of approximately 130 positions.  During the second quarter, the 
Company also executed a lease for a 30,000 square-foot office site located 
in Cortland, New York and the relocation of headquarters occurred in March 
of 1999.

The Company continues to refine its business plan which calls for the 
expansion and diversification of its product lines with a renewed emphasis 
on building on the market's recognition of the Smith Corona brand in 
printed document and data transmission.  The Company believes it can 
strengthen its global business in typewriter and related accessories and 
supplies and headsets by expanding its sales capabilities and by revising 
its marketing programs.

In keeping with its history of marketing products related to printed 
document production, the Company is also negotiating with numerous 
suppliers to expand product lines and develop new product lines in speech 
recognition products, inkjet printer supplies and digital photo printers 
and supplies. As a result the Company has de-emphasized its domestic 
telephony and facsimile products. 

The Company anticipates introducing the first of these newly sourced 
products in the first quarter of fiscal 2000.  The Company intends to rely 
on its existing distribution network to market its products to the small 
office/home office (SOHO) market, as well as expand to new channels of 
distribution and to increase its emphasis on international markets.  The 
Company's success depends on its ability to successfully source, market and 
sell its products while continuing to implement cost controls to keep 
expenses in line with revenues.

Net sales of $11.9 million for the quarter ended March 31, 1999 decreased 
21.2 percent from last year's third quarter net sales of $15.1 million.  
For the nine month period ended March 31, 1999, net sales were $35.8 
million, a 23.7 percent decrease from last year's comparable period of 
$46.9 million.  Unit sales of typewriters and related accessories and 
supplies are lower than a year ago, as a result of a shrinking market and a 
continuing difficult and competitive environment.  However, industry data 
indicates that the rate of decline is slowing to single digit levels.  The 
lower volumes are partially offset by newly sourced product net sales of 
$2.1 million for the three months ended March 31, 1999 and $5.7 million for 
the nine months ended March 31, 1999.  The prior year comparable three and 
nine month periods ended March 31, 1998 included $1.5 million and $2.0 
million, respectively, in newly sourced product sales.

Gross margin, as a percentage of net sales, was (2.7) percent for the third 
quarter ended March 31, 1999, as compared to 29.8 percent for the 
comparable period last year.  For the nine months ended March 31, 1999 the 
gross margin as a percentage of net sales was (0.1) percent as compared to 
26.7 percent last year.  Gross margins in the three and nine months ended 
March 31, 1999 were negatively affected by clearance sales of low-end 
telephony and facsimile products.  In the fourth quarter of the Company's 
1998 fiscal year competitors began reducing market prices for the low-end 
telephony and facsimile products.  These sharp price declines resulted in 
the Company having to reduce its low-end telephony and facsimile product 
pricing and record related inventory writedowns at the end of fiscal year 
1998 and during the first nine months of fiscal year 1999.  The nine months 
ended March 31, 1999 was adversely impacted by a charge of approximately 
$2.2 million for additional inventory related writedowns.  In the third 
quarter a substantial portion of the remaining low-end telephony and 
facsimile products inventory were sold and therefore, gross margins are 
expected to increase in the fourth quarter.

The Company's current procurement contract for typewriters and related 
supplies and accessories provides for retroactive price increases in 
certain circumstances including shortfalls in actual purchases versus those 
forecasted.  Due to shortfalls from forecasted purchases, the Company has 
incurred approximately $2.4 million in retroactive price increases for the 
nine months ending March 31, 1999 which includes an estimated additional 
$.8 million relating to expected shortfalls in the fourth quarter.  The 
Company continues discussions with its supplier to eliminate, along with 
other contractual items, the retroactive price increase provisions of the 
contract particularly for the remainder of this fiscal year.  The ultimate 
retroactive price increase for the three months ending June 30, 1999 
depends on the actual level of purchases, the outcome of discussions with 
its supplier and the outcome of certain other contract provisions.

Selling, general and administrative expenses for the three and nine months 
ended March 31, 1999 were $4.6 million and $15.4 million as compared to 
$7.7 million and $19.8 million last year.  The decrease in spending from 
the prior year was primarily associated with sharp declines in spending to 
support development and advertising of newly sourced products along with 
reduced expenses associated with the September 1998 restructuring action.

In the first quarter ended September 30, 1998, the Company reevaluated 
its strategy and focus and the deployment of its resources to take 
advantage of new and existing opportunities.  As a result of this 
evaluation, management determined, among other things, that the 
Company needed to continue transitioning its administrative cost 
structure from that of a manufacturing company to one of a sales and 
marketing company.

In connection with this strategic initiative, the Company announced a 
restructuring plan on September 28, 1998 and recorded a related pre-tax 
and post-tax charge of $1.3 million in the nine months ended March 31, 
1999.  The substantial portion of this charge relates to the severance 
cost associated with the termination of approximately 130 positions, 
primarily at the Company's Cortland, New York corporate headquarters.  
The affected employees were identified and notified on September 28, 
1998.  To a much lesser extent the restructuring charge also includes 
provisions related to a planned sale of the furnishings and equipment 
located at the corporate headquarters.  

In connection with the restructuring, the Company planned to sell its 
Cortland facility at 839 State Route 13 South, Cortland, New York.  The 
facility sale was completed on April 2, 1999 as further described below.  
The Smith Corona headquarters remains in Cortland, New York but was moved 
in March 1999 to a more efficient facility located at 842 Bennie Road, 
Cortland, New York.  The related net book value  of the facility held for 
sale has been reclassified to other assets on the March 31, 1999 balance 
sheet. 

Management believes that the workforce reductions, relocation to more 
efficient facilities and the continued efforts to reduce certain targeted 
costs such as advertising and new product development will reduce expenses 
by approximately $9.0 million annually.

The Company believes its products and major operating systems are year 2000 
compliant.  The Company is in the process of gathering information 
concerning the year 2000-compliance status of its suppliers.  In the event 
that any of the Company's significant suppliers do not successfully and 
timely achieve year 2000 compliance, the Company's business could be 
adversely affected.  Any significant disruption of the Company's ability to 
communicate electronically with its business partners could negatively 
impact the Company's business.

Financial Condition

The Company's primary source of liquidity and capital resources, on both a 
short- and long-term basis, are cash balances and available borrowing 
capacity.

On February 10, 1999, the Company and its lender executed a waiver and 
amendment to its loan and security agreement (the "Loan and Security 
Agreement").  Pursuant to the provisions of the waiver and amendment, the 
Company must maintain an adjusted net worth of not less than one dollar 
through June 29, 1999 and $2.0 million thereafter.  Management believes 
that it will have adequate financing flexibility under the Loan and 
Security Agreement, as amended.

During the nine months ended March 31, 1999, the Company's operating 
activities used $9.0 million of cash, primarily as a result of the net 
loss.  Accounts receivable decreased $3.2 million, which corresponds with 
the sales activity levels in the period.  The net decrease in inventories 
of $3.6 million was primarily due to the clearing out of low-end telephony 
and facsimile products.  Capital expenditures for the nine months ended 
March 31, 1999 were $.4 million and are primarily related to new product 
tooling and the office renovation of its new facility.  The Company had no 
material commitments for additional capital expenditures at March 31, 1999.

On April 2, 1999, the Company completed the sale of its 422,000 square-foot 
former manufacturing facility and tool room equipment and operations.  
Additionally, the buyer agreed to complete operation, maintenance, 
monitoring, shutdown and post-shutdown activities of the remediation 
systems at the Cortlandville Site.  Although the buyer agreed to complete 
such remediation activities, the Company remains the primary obligor with 
the environmental authorities and as such will continue to carry the 
associated estimated liability for remediation activities on its balance 
sheet.  The net cash proceeds from the sale were approximately $2.0 million 
and the Company expects to record a fourth quarter pre-tax and post-tax 
gain of approximately $.3 million from the transaction.

The Company believes that its cash and borrowing capabilities will be 
sufficient to meet its operating cash and capital expenditure requirements 
in the foreseeable future.


PART II - Other Information

Item 1.	Legal Proceedings.

Information required by this item is incorporated by reference from "Note 2 
- Contingencies" in the Notes to the Consolidated Financial Statements 
appearing in this Form 10-Q Quarterly Report.



Item 6.	Exhibits and Reports on Form 8-K

  (a)  Exhibits

10.1  Waiver and Amendment to Financing Agreement dated 
      February 10, 1999

10.2  Amendment to Loan and Security Agreement dated April 
      1, 1999 

27    Financial Data Schedule

(b) Reports on Form 8-K

None



                             SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.









SMITH CORONA CORPORATION




May 13, 1999

                                By: /s/ Martin D. Wilson
                                     Martin D. Wilson
                                     Senior Vice President &
                                     Chief Financial Officer
                                     (Principal Financial and 
                                      Accounting Officer) 

EXHIBIT INDEX

Exhibit No.		Description

10.1             Waiver and Amendment to Financing Agreement dated 
                 February 10, 1999

10.2	            Amendment to Loan and Security Agreement date April 1, 
                 1999

27  	            Financial Data Schedule